Intracerebral human regulatory T cells: Analysis of CD4+CD25+FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Fritzsching, Benedikt ^a   Haas, Jürgen ^a   König, Fatima ^b,d   Kunz, Pierre ^a   Fritzsching, Eva ^a   Pöschl, Johannes ^a   Krammer, Peter H ^c   Brück, Wolfgang ^b   Suri Payer, Elisabeth ^c   Wildemann, Brigitte ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45RO ANTIGEN; FAS ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; CD45 ANTIGEN; FAS PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BRAIN BIOPSY; BRAIN DAMAGE; CD4+ CD25+ T LYMPHOCYTE; CEREBROSPINAL FLUID; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; LYMPHOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; MULTIPLE SCLEROSIS; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; BRAIN; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANTIGENS, CD45; ANTIGENS, CD95; BRAIN; CHEMOTAXIS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE SUBSETS; MULTIPLE SCLEROSIS; T-LYMPHOCYTES, REGULATORY;

EID: 79952788103     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017988     Document Type: Article

References (45)

1. Ota K, Matsui M, Milford EL, Mackin GL, Weiner HL, et al. (1990) T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346: 183-187.
2. Pullen AM, Marrack P, Kappler JW, (1989) Evidence that Mls-2 antigens which delete V beta 3+ T cells are controlled by multiple genes. J Immunol 142: 3033-3037.
3. Cvetanovich GL, Hafler DA, (2010) Human regulatory T cells in autoimmune diseases. Curr Opin Immunol doi:10.1016.
4. Sakaguchi S, Yamaguchi T, Nomura T, Ono M, (2008) Regulatory T cells and immune tolerance. Cell 133: 775-787.
5. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA, (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199: 971-979.
6. Haas J, Hug A, Viehöver A, Fritzsching B, Falk CS, et al. (2005) Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol 35: 3343-3352.
7. Venken K, Hellings N, Thewissen M, Somers V, Hensen K, et al. (2008) Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 123: 79-89.
8. Haas J, Fritzsching B, Trübswetter P, Korporal M, Milkova L, et al. (2007) Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol 179: 1322-1330.
9. Venken K, Hellings N, Broekmans T, Hensen K, Rummens JL, et al. (2008) Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. J Immunol 180: 6411-6420.
10. Pender MP, (1998) Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis. Lancet 351: 978-981.
11. Comi C, Leone M, Bonissoni S, DeFranco S, Bottarel F, et al. (2000) Defective T cell fas function in patients with multiple sclerosis. Neurology 55: 921-927.
12. Macchi B, Matteucci C, Nocentini U, Caltagirone C, Mastino A, (1999) Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis. Neuroreport 10: 399-402.
13. Sharief MK, (2000) Impaired fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis. J Neuroimmunol 109: 236-243.
14. Fritzsching B, Oberle N, Eberhardt N, Quick S, Haas J, et al. (2005) In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. J Immunol 175: 32-36.
15. Fritzsching B, Korporal M, Haas J, Krammer PH, Suri-Payer E, et al. (2006) Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals. J Neurol Sci 251: 91-97.
16. Vukmanovic-Stejic M, Zhang Y, Cook JE, Fletcher JM, McQuaid A, et al. Human CD4+CD25hiFoxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 116: 2423-2433.
17. Fritzsching B, Oberle N, Pauly E, Geffers R, Buer J, et al. (2006) Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 108: 3371-3378.
18. Bettini M, Vignali DA, (2009) Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 21: 612-618.
19. Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, et al. (2008) Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 172: 146-155.
20. Klemke CD, Fritzsching B, Franz B, Kleinmann EV, Oberle N, et al. (2006) Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas. Leukemia 20: 1123-1129.
21. Franz B, Fritzsching B, Riehl A, Oberle N, Klemke CD, et al. (2007) Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum 56: 1910-1920.
22. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, et al. (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47: 707-717.
23. Feger U, Luther C, Poeschel S, Melms A, Tolosa E, et al. (2007) Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin Exp Immunol 147: 412-418.
24. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, et al. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203: 1701-1711.
25. Nishikawa H, Sakaguchi S, (2010) Regulatory T cells in tumor immunity. Int J Cancer 127: 759-767.
26. Haas J, Schopp L, Storch-Hagenlocher B, Fritzsching B, Jacobi C, et al. (2008) Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis. Blood 111: 761-766.
27. Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, et al. (2009) Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis. Ann Neurol 66: 171-183.
28. Stenner MP, Waschbisch A, Buck D, Doerck S, Einsele H, et al. (2008) Effects of natalizumab treatment on Foxp3+ regulatory cells. PLoS One 3: e3319.
29. Nyland H, Mork S, Matre R, (1982) In-situ characterization of mononuclear cell infiltrates in lesions of multiple sclerosis. Neuropathol Appl Neurobiol 8: 403-411.
30. Traugott U, Reinherz EL, Raine CS, (1983) Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 219: 308-310.
31. Hauser SL, Bhan AK, Gilles F, Kemp M, Kerr C, et al. (1986) Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol 19: 578-587.
32. Woodroofe MN, Bellamy AS, Feldmann M, Davison AN, Cuzner ML, (1986) Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth. J Neurol Sci 74: 135-152.
33. Sonabend AM, Rolle CE, Lesniak MS, (2008) The role of regulatory T cells in malignant glioma. Anticancer Res 28: 1143-1150.
34. Gritzapis AD, Voutsas IF, Lekka E, Papamichail M, Baxevanis CN, (2010) Peptide vaccination breaks tolerance to HER-2/neu by generating vaccine-specific FasL(+) CD4(+) T cells: first evidence for intratumor apoptotic regulatory T cells. Cancer Res 70: 2686-2696.
35. Chen A, Liu S, Park D, Kang Y, Zheng, (2007) Depleting intratumoral CD4+CD25+ regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T cell transfer. Cancer Res 67: 1291-1298.
36. Liu S, Breiter DR, Zheng G, Chen A, (2007) Enhanced antitumor responses elicited by combinatorial protein transfer of chemotactic and costimulatory molecules. J Immunol 178: 3301-3306.
37. Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, et al. (2008) Central role of defective Interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
38. Michel L, Berthelot L, Pettré S, Wiertlewski S, Lefrère F, et al. (2008) Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis. J Clin Invest 118: 3411-3419.
39. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol 13: 227-231.
40. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, et al. (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128: 2705-2712.
41. Prineas JW, (1985) The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, Klawans HL, editors. Handbook of clinical neurology pp. 213-257.
42. Brück W, Porada P, Poser S, Rieckmann P, Hanefeld F, et al. (1995) Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 38: 788-796.
43. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127.
44. Schneider-Hohendorf Stenner MP, Weidenfeller C, Zozulya AL, Simon OJ, et al. (2010) Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis. Eur J Immunol 40: 3581-90.
45. Sakaguchi S, Miyara M, Costantino CM, Hafler DA, (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490-500.